These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 6948897)

  • 21. Normal and malignant human myelocytic and monocytic cells identified by monoclonal antibodies.
    Bernstein ID; Andrews RG; Cohen SF; McMaster BE
    J Immunol; 1982 Feb; 128(2):876-81. PubMed ID: 6948042
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antibody-targeted therapy for myeloid leukemia.
    Appelbaum FR
    Semin Hematol; 1999 Oct; 36(4 Suppl 6):2-8. PubMed ID: 10530710
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Monoclonal antibody against a unique antigen on human acute promyelocytic leukemia cell line (HL-60).
    Aota F; Chang D; Hill NO; Khan A
    Exp Hematol; 1982 Nov; 10(10):835-43. PubMed ID: 6759147
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human leukocyte markers defined by monoclonal antibodies. I. Expression of X-hapten structure on cells of myeloid lineage.
    Koubek K; Korínkovà P; Hrubà A; Hausner P
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(6):913-26. PubMed ID: 2467863
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Antibody-dependent cytotoxicity of lymphocytes in acute myeloblastic leukemia and chronic myelocytic leukemia].
    Tishchenko LM; Guseva SA
    Eksp Onkol; 1987; 9(2):66-7. PubMed ID: 3472877
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antibodies TC-12 ("unique") and TH-111 (CD96) characterize T-cell acute lymphoblastic leukemia and a subgroup of acute myeloid leukemia.
    Gramatzki M; Ludwig WD; Burger R; Moos P; Rohwer P; Grünert C; Sendler A; Kalden JR; Andreesen R; Henschke F; Moldenhauer G
    Exp Hematol; 1998 Dec; 26(13):1209-14. PubMed ID: 9845376
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Continuous infusion of complement by an automated cell processor enhances cytotoxicity of monoclonal antibody sensitized leukemia cells.
    Howell AL; Fogg-Leach M; Davis BH; Ball ED
    Bone Marrow Transplant; 1989 May; 4(3):317-22. PubMed ID: 2659117
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antileukemia activity of a natural killer cell line against human leukemias.
    Yan Y; Steinherz P; Klingemann HG; Dennig D; Childs BH; McGuirk J; O'Reilly RJ
    Clin Cancer Res; 1998 Nov; 4(11):2859-68. PubMed ID: 9829753
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Selective cytotoxicity of the SM1 monoclonal antibody towards small cell carcinoma of the lung.
    Bernal SD; Mabry M; Stahel RA; Griffin JD; Speak JA
    Cancer Res; 1985 Mar; 45(3):1026-32. PubMed ID: 2982482
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Restricted expression of an early myeloid and monocytic cell surface antigen defined by monoclonal antibody M195.
    Tanimoto M; Scheinberg DA; Cordon-Cardo C; Huie D; Clarkson BD; Old LJ
    Leukemia; 1989 May; 3(5):339-48. PubMed ID: 2716349
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Matrix metalloproteinase production by bone marrow mononuclear cells from normal individuals and patients with acute and chronic myeloid leukemia or myelodysplastic syndromes.
    Ries C; Loher F; Zang C; Ismair MG; Petrides PE
    Clin Cancer Res; 1999 May; 5(5):1115-24. PubMed ID: 10353746
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acute myelogenous leukemia blasts as accessory cells during in vitro T lymphocyte activation.
    Bruserud O; Ulvestad E
    Cell Immunol; 2000 Nov; 206(1):36-50. PubMed ID: 11161436
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The use of myeloid-specific monoclonal antibodies in the diagnosis of leukemia.
    Ball ED; Fanger MW
    Diagn Immunol; 1983; 1(2):90-5. PubMed ID: 6209052
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of human monoclonal antibody 216 on B-progenitor acute lymphoblastic leukemia in vitro.
    Bieber MM; Twist CJ; Bhat NM; Teng NN
    Pediatr Blood Cancer; 2007 Apr; 48(4):380-6. PubMed ID: 16421902
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vim-2, candidate monoclonal antibody for purging autologous marrow grafts in acute myeloblastic leukaemia.
    Delwel R; Bot F; Knapp W; Löwenberg B
    Bone Marrow Transplant; 1987 Aug; 2(2):149-54. PubMed ID: 3332163
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Monoclonal antibodies against IREM-1: potential for targeted therapy of AML.
    Korver W; Zhao X; Singh S; Pardoux C; Zhao J; Guzman ML; Sen S; Yonkovich S; Liu S; Zhan X; Tomasevic N; Zhou C; Gros D; Jordan CT; Gotlib J; Hsi ED; Abo A
    Leukemia; 2009 Sep; 23(9):1587-97. PubMed ID: 19440216
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Monoclonal antibody against a differentiation antigen on human leukemia cells: cross-reactivity with rat leukemia and suppression of rat leukemia in vivo.
    Johnson RJ; Shin HS
    J Immunol; 1983 Jun; 130(6):2930-6. PubMed ID: 6406599
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression patterns of costimulatory molecules on cells derived from human hematological malignancies.
    Zheng Z; Takahashi M; Aoki S; Toba K; Liu A; Osman Y; Takahashi H; Tsukada N; Suzuki N; Nikkuni K; Furukawa T; Koike T; Aizawa Y
    J Exp Clin Cancer Res; 1998 Sep; 17(3):251-8. PubMed ID: 9894758
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Monoclonal antibodies to the L1210 murine leukemia cell line and to a drug-altered subline.
    Testorelli C; Archetti YL; Aresca P; Del Vecchio L
    Cancer Res; 1985 Nov; 45(11 Pt 1):5299-303. PubMed ID: 4053006
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Monoclonal antibodies to a glycolipid antigen on human neuroblastoma cells.
    Cheung NK; Saarinen UM; Neely JE; Landmeier B; Donovan D; Coccia PF
    Cancer Res; 1985 Jun; 45(6):2642-9. PubMed ID: 2580625
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.